Bimeda has forged a joint venture firm in Shijiazhuang in northern China to develop and manufacture veterinary and animal health products for the Chinese and Asian regional market.
The 50-50 joint venture between Bimeda and Shijiazhuang Rainbow Laboratories will initially provide product stability and raw materials testing for the pharmaceutical industry. The state of the art facility operates to the principals of Good Laboratory practise (GLP) & is ISO 9001 accredited. FDA approval of the Laboratory is pending but is expected imminently. It will be the initial platform for expected further investment by Bimeda in the Chinese market. Employing twenty analysts developing new products, new raw materials for the multi-jurisdictions of the Bimeda brand ''The demand for animal health products in China will increase and this will lift the Chinese animal health market and other international veterinary markets in the region'' said Bimeda group chief executive Donal Tierney.
Bimeda acquires Assia Animal Health, formally a subsidiary of Phibro Animal Health Inc. Bimeda has relocated its East African headquarters to Kenya.
Today Bimeda's East African market share is the largest in the animal health pharmaceutical sector.
Bimeda are delighted to announce the appointment of Mr. Padraig Hyland as Commercial Veterinarian to the expanding team. Padraig will be vital to the company's future growth and expansion. He will ensure that Bimeda is positioned as a leader in the area of animal health.
Mr. Tom Kelleher, Head of Sales and Marketing, Ireland and UK, welcomed Mr. Hyland to the company and said, "At Bimeda we are committed to providing and extensive range of top quality animal health products. We are determined to be market leaders in providing cost effective animal health solutions. Padraig brings considerable practical experience and knowledge of the challenges that face our customers on a daily basis."
Commenting on his appointment, Mr. Padraig Hyland said "I am very pleased with the opportunity to work for Bimeda. This is a progressive company with a leading product range. Bimeda invests heavily in R&D which ensures that it will grow and thrive in a competitive market".
Currently, Bimeda is a major player in the veterinary pharmaceutical market manufacturing and distributing more than 100 products to a diverse animal health market worldwide. Success has come from high quality products, superior product formulation and meeting the needs of our customers.